United States Neurological Biomarkers Market Share, Growth, Analysis, Size, Trends, Report 2025-2033
25 Mar, 2025
United States Neurological Biomarkers Market Outlook
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 6.1 Billion
Market Forecast in 2033: USD 9.5 Billion
Market Growth Rate: 5% (2025-2033)
The United States neurological biomarkers market size reached USD 2.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.3 Billion by 2033, exhibiting a growth rate (CAGR) of 12.7% during 2025-2033.
United States Neurological Biomarkers Market Trends:
The neurological biomarkers market in the United States is quickly growing due to the rising incidence of neurological illnesses, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis will increase the need for better diagnostics and prognosis solutions. Increased funding for research and development, accompanied by advances in technology, is driving growth within this market, as well. Additionally, the increasing adoption of precision medicine and personalized treatment paradigms is producing the need for reliable biomarkers for early detection of disease and monitoring of disease. At the same time, pharmaceutical and biotechnology companies (and the study of new biomarker-based therapeutics) are leading to partnerships with research institutions, further increasing market opportunities.
In a similar vein, the regulatory environment is evolving to support biomarker validation and agency approval processes is supporting biomarker use in clinical practice. Use (or preclinical use) of artificial intelligence and machine learning in biomarker is also enhancing accuracy. Finally, an increase in the number of biomarkers in clinical trial development with pharmaceuticals is promoting product innovation and improving patient outcomes. In addition, the increasing interest in biomarkers for neurodegenerative and psychiatric disorders is opening new avenues for commercializing research. Therefore, the neurological biomarkers market in the United States will continue to develop over time through scientific knowledge, regulatory facilitation, and need for early, accurate, and reliable clinical diagnoses.
United States Neurological Biomarkers Market Scope and Growth Analysis:
The market for neurological biomarkers in the United States is rapidly growing due to the increasing incidence of neurological diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. As an extension of this, the increased use of biomarker-based diagnostics in both clinical research and personalized medicine can also enhance market growth. In particular, advances in the fields of proteomics, genomics, and imaging technologies are making biomarker discovery more accessible and improving diagnosis and monitoring of treatment. Moreover, the market is buoyed by an increasing flow of funding to neurological research from pharmaceutical and biotechnology companies and government initiatives. Another development contributing to market growth is the incorporation of artificial intelligence and machine learning in some biomarker diagnostics, which may lead to better and more efficient diagnostic tools.
Additionally, the biomarker landscape is evolving as the market continuously increases the relevance of biomarkers in the drug discovery and clinical trial context. The increase in the aging population, who are likely to experience an increase in these neurological disorders, is contributing to market rates of growth. On the whole, increasing awareness from both healthcare providers and patients has led to a greater understanding of the benefits of early detection of disease. At the same time, academic institutions and the industry are collaborating in ways that will encourage innovation and leads to biomarker diagnostics, which will further piquing interest in biomarkers. Overall, it is likely that the U.S. neurological biomarker market will continue to grow due to advances in technology and increasing accessibility of funds as more and more discover, realize and experience their relevance.
United States Neurological Biomarkers Market Report Segmentation:
The market report offers a comprehensive analysis of the segments, highlighting those with the largest United States neurological biomarkers market share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.
Type Insights:
Genomic Biomarkers
Proteomic Biomarkers
Metabolomic Biomarkers
Imaging Biomarkers
Others
Application Insights:
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Autism Spectrum Disorders
Others
End Use Insights:
Hospital Laboratories
Clinical Diagnostic Centers
Research Organizations
Others
Regional Insights:
Northeast
Midwest
South
West
Competitive Landscape:
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
Key highlights of the Report:
Recent Industry News
Key Technological Trends & Development
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Strategic Recommendations
Market Dynamics
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Top Winning Strategies
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
The global chemical logistics market size reached US$ 235.1 Billion in 2023 & projected to reach US$ 301.1 Billion, CAGR of 2.7% during forecast 2024-2032.
Write a comment ...